Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 28.8T | 29.4T | 30.7T | 28.7T |
Cost of revenue | 23.8T | 24.6T | 25.6T | 24.8T |
Gross profit | 5.0T | 4.8T | 5.1T | 3.9T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.6T | 3.2T | 2.7T | 2.8T |
Other operating expenses | — | — | — | — |
Operating income | 2.4T | 1.6T | 2.4T | 1.1T |
Non operating interest income | ||||
Income | 94.9B | 187.8B | 171.0B | 170.2B |
Expense | 7.5B | 6.6B | 6.8B | 6.8B |
Other income expense | — | — | — | — |
Pretax income | 2.6T | 2.0T | 2.4T | 1.4T |
Tax provision | 640.0B | 592.2B | 539.1B | 288.5B |
Net income | 1.9T | 1.4T | 1.9T | 1.1T |
Basic EPS | 16 | — | — | — |
Diluted EPS | 16 | — | — | — |
Basic average shares | 1.9Qa | — | — | — |
Diluted average shares | 1.9Qa | — | — | — |
EBITDA | 2.6T | 2.0T | 2.5T | 1.4T |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |